Ekos Endovascular Device
FDA Clearance Information
The EKOS Endovascular Device was cleared by the FDA via the 510(k) pathway on April 20, 2022. It is manufactured by Boston Scientific and classified as a Class 2 device.
What It Is
FDA-Cleared Indications
- Used to facilitate the infusion of thrombolytic agents into blood clots in the peripheral vasculature.
- Used to facilitate the infusion of thrombolytic agents into pulmonary emboli.
- Used with thrombolytic medication to assist clot dissolution in appropriately selected patients.
Clinical Applications
- Catheter-directed, ultrasound-assisted thrombolysis for selected pulmonary embolism.
- Catheter-directed treatment of selected lower-extremity deep vein thrombosis.
- Treatment of venous thromboembolism when targeted thrombolytic infusion is clinically appropriate.
- Use during image-guided endovascular procedures in which a thrombolytic agent is delivered directly into a clot.
Reported off-label uses
- Use in selected thrombosed dialysis grafts or fistulas as part of catheter-directed thrombolysis or thrombectomy strategies.
- Use in other peripheral venous thromboses not specifically covered by the device's cleared labeling.
Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- The system is used with a compatible catheter, guidewire, ultrasound-control equipment and a prescribed thrombolytic medication; the device does not dissolve clot without medication.
- Access is commonly obtained through a peripheral venous site, such as the femoral or popliteal vein, depending on the clot location and treatment plan.
- Available catheter configurations and working lengths vary; the treating team must match catheter size, length and infusion segment to the vessel and clot anatomy.
- Patients require careful assessment for bleeding risk, including recent surgery, active bleeding, intracranial hemorrhage, severe uncontrolled hypertension and other contraindications to thrombolytic therapy.
- MRI compatibility depends on the specific catheter and system configuration. The exact device labeling should be checked before MRI, and the catheter should not be assumed to be safe in the scanner.
Procedures that use this device
Linked Studies (20)
Real-world clinical outcomes of EKOS catheter-directed thrombolysis versus systemic alteplase in acute pulmonary embolism: a retrospective cohort study.
Frontiers in pharmacology
RCT|prospective|retrospective|case Series|other View Source →Novel Phase Shift Microbubbles, MVT-101, Enhance Sonothrombolysis in a Porcine Model of Deep Vein Thrombosis.
Nanotheranostics
View Source →[Interventional therapy of pulmonary embolism - update].
Deutsche medizinische Wochenschrift (1946)
RCT|prospective|retrospective|case Series|other View Source →Initiating and imaging cavitation from infused echo contrast agents through the EkoSonic catheter.
Scientific reports
RCT|prospective|retrospective|case Series|other View Source →[Ultrasound-accelerated thrombolysis. Initial experience in patients with contraindications to systemic thrombolysis].
Revista medica del Instituto Mexicano del Seguro Social
RCT|prospective|retrospective|case Series|other View Source →Quantifying the Effect of Acoustic Parameters on Temporal and Spatial Cavitation Activity: Gauging Cavitation Dose.
Ultrasound in medicine & biology
RCT|prospective|retrospective|case Series|other View Source →Treatment With EkoSonic™ Endovascular System (EKOS®) of Massive Pulmonary Thrombosis Following Recovery From COVID-19 Infection.
Cureus
RCT|prospective|retrospective|case Series|other View Source →EkoSonic™ Endovascular System-Directed Thrombolysis in a Patient With COVID-19 Infection Presenting With Bilateral Large Pulmonary Embolism Causing Right Ventricular Strain: A Case Report.
Cureus
Case Report View Source →Analysis of pulmonary embolism patients treated with EkoSonic™ endovascular system.
Turk gogus kalp damar cerrahisi dergisi
RCT|prospective|retrospective|case Series|other View Source →Successful Thrombolysis of Acute Upper Limb Ischemia Using Ekosonic Endovascular System Ultrasound Catheter in a Patient With Atrial Fibrillation.
Cardiovascular revascularization medicine : including molecular interventions
Case Series View Source →Stability of alteplase for ultrasound-facilitated catheter-directed thrombolysis.
Blood advances
RCT|prospective|retrospective|case Series|other View Source →Massive pulmonary embolism in patients with extreme bleeding risk: a case series on the successful use of ultrasound-assisted, catheter directed thrombolysis in a district general hospital.
Journal of thrombosis and thrombolysis
Case Series View Source →EKOS™ Jena Experience: Safety, Feasibility, and Midterm Outcomes of Percutaneous Ultrasound-Assisted Catheter-Directed Thrombolysis in Patients with Intermediate-High-Risk or High-Risk Pulmonary Embolism.
Canadian respiratory journal
RCT|prospective|retrospective|case Series|other View Source →Cavitation Emissions Nucleated by Definity Infused through an EkoSonic Catheter in a Flow Phantom.
Ultrasound in medicine & biology
View Source →Hemodynamic Effects of Ultrasound-Assisted, Catheter-Directed, Very Low-Dose, Short-Time Duration Thrombolysis in Acute Intermediate-High Risk Pulmonary Embolism (from the EKOS-PL Study).
The American journal of cardiology
RCT|prospective|retrospective|case Series|other View Source →Ekosonic Endovascular System (EKOS) in a trauma patient with intracranial bleed, recent major surgery, and massive pulmonary embolus: A case report.
Radiology case reports
Case Report View Source →EkoSonic Thrombolysis as a Therapeutic Adjunct in Venous Occlusive Disease.
The International journal of angiology : official publication of the International College of Angiology, Inc
Retrospective|case Series View Source →The Role of EkoSonic Endovascular System or EKOS® in Pulmonary Embolism.
Cureus
RCT|prospective|retrospective|case Series|other View Source →EkoSonic® endovascular system and other catheter-directed treatment reperfusion strategies for acute pulmonary embolism: overview of efficacy and safety outcomes.
Expert review of medical devices
RCT|prospective|retrospective|case Series|other View Source →Real-World Outcomes of EKOS Ultrasound-Enhanced Catheter-Directed Thrombolysis for Acute Limb Ischemia.
Annals of vascular surgery
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What are the clinical indications for EKOS Endovascular Device?
The device is indicated for use in mechanical thrombectomy for venous thromboembolic conditions, such as pulmonary embolism and deep vein thrombosis.
What outcomes have been reported in clinical studies?
Clinical studies have reported effective clot resolution and improved limb salvage rates, with some variations based on patient demographics.
What complications have been reported?
Safety data indicate bleeding events as a primary complication, though the device is generally considered safe compared to systemic thrombolysis.